Munafa Stock Market Course + Intraday & FNO calls 
Akebia Therapeutics (AKBA) Technical (Analysis) Reports Akebia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akebia Therapeutics (AKBA)
Technical Analysis Report for USA stock AKBA Akebia Therapeutics. Dated: 30 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKBA Akebia Therapeutics then click here. or read Experts views on Akebia Therapeutics or Forecast & share price targets of Akebia Therapeutics
Akebia Therapeutics Opened at 0.72 and Closed at: 0.71, which is -4.23% of previous session's close. It moved within a range of 0.70 and 0.73
The session was a Bearish session with an average volume of 2776800, which is -58.41% of previous session's volumes.
Support for tomorrow is 0.69 and resistance for tomorrow is 0.72
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.7, 0.68 resistance for tomorrow's hourly charts is 0.73, 0.74
10 Day SMA for Akebia Therapeutics (AKBA) is 0.65 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Akebia Therapeutics (AKBA) is 0.72 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Akebia Therapeutics (AKBA) is 0.85 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Akebia Therapeutics is 1.15 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Akebia Therapeutics is at 0.72 and 200 DMA is at 1.15, while 50 DMA and 100 DMA are at 0.85 and 1 respectively
Akebia Therapeutics (AKBA) moving average of 20 SMA is at 0.72 and 20 EMA is at 0.71
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Oct | 0.71 | 0.72 | 0.71 |
| 29 Thu Oct | 0.74 | 0.73 | 0.71 |
| 28 Wed Oct | 0.76 | 0.74 | 0.71 |
| 27 Tue Oct | 0.66 | 0.74 | 0.71 |
| 26 Mon Oct | 0.65 | 0.76 | 0.72 |
| 23 Fri Oct | 0.57 | 0.77 | 0.73 |
Akebia Therapeutics (AKBA) moving average of 50 SMA is at 0.85 and 50 EMA is at 0.84
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Oct | 0.71 | 0.85 | 0.84 |
| 29 Thu Oct | 0.74 | 0.85 | 0.85 |
| 28 Wed Oct | 0.76 | 0.85 | 0.85 |
| 27 Tue Oct | 0.66 | 0.86 | 0.85 |
| 26 Mon Oct | 0.65 | 0.86 | 0.86 |
| 23 Fri Oct | 0.57 | 0.86 | 0.87 |
Akebia Therapeutics (AKBA) moving average of 100 SMA is at 1 and 100 EMA is at 0.97
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Oct | 0.71 | 1 | 0.97 |
| 29 Thu Oct | 0.74 | 1 | 0.98 |
| 28 Wed Oct | 0.76 | 1 | 0.98 |
| 27 Tue Oct | 0.66 | 1 | 0.98 |
| 26 Mon Oct | 0.65 | 1.01 | 0.99 |
| 23 Fri Oct | 0.57 | 1.01 | 1 |
Akebia Therapeutics (AKBA) moving average of 200 SMA is at 1.15 and 200 EMA is at 1.22
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Oct | 0.71 | 1.15 | 1.22 |
| 29 Thu Oct | 0.74 | 1.15 | 1.23 |
| 28 Wed Oct | 0.76 | 1.15 | 1.23 |
| 27 Tue Oct | 0.66 | 1.16 | 1.23 |
| 26 Mon Oct | 0.65 | 1.16 | 1.24 |
| 23 Fri Oct | 0.57 | 1.16 | 1.25 |
Stryker Corporation has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Stryker Corporation, about 24.97% more returns!
Steris Plc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Steris Plc, about 30.43% more returns!
Pfizer Inc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Pfizer Inc, about 34.1% more returns!
Centene Corporation has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Centene Corporation, about 29.3% more returns!
Bristol Myers has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Bristol Myers, about 29.07% more returns!
Bausch Health has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Bausch Health, about 62.05% more returns!
Veru Inc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Veru Inc, about 8.71% more returns!
China Sxt has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in China Sxt, about 82.14% more returns!
Sanofi has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Sanofi, about 35.05% more returns!
Redhill Biopharma has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Redhill Biopharma, about 2.42% more returns!
Gossamer Bio has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Gossamer Bio, about 20.29% more returns!
Guardant Health has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Guardant Health, about 18.28% more returns!
Akebia Therapeutics has performed better than Dariohealth Corp in short term. Holding Akebia Therapeutics could be a better choice for now!
Champions Oncology has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 19.61% more returns!
Akebia Therapeutics has performed better than Coherus Biosciences in short term. Holding Akebia Therapeutics could be a better choice for now!
Biogen Inc has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Biogen Inc, about 36.26% more returns!
Akebia Therapeutics has performed better than Anavex Life in short term. Holding Akebia Therapeutics could be a better choice for now!
Apyx Medical has performed better than Akebia Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 22.83% more returns!
Akebia Therapeutics Technical analysis of indicators
Price action analysis of Akebia Therapeutics (AKBA) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Akebia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Akebia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akebia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color Prices appear to be coming down
CCI has generated a SELL signal for Akebia Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.63 and Akebia Therapeutics AKBA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Akebia Therapeutics AKBA stock. Volume based technical analysis of Akebia Therapeutics AKBA stock is negative.
Akebia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKBA Akebia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKBA Experts View which covers a lot of information including buying and selling signals
AKBA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akebia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akebia Therapeutics (AKBA) Technical (Analysis) Reports Akebia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
